Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V SHEEHAN

Showing results (11-20 of 195) with videos related to

Pageof 20
Sort By:
The Journal of Clinical Psychiatry|February 4, 2003
The management of panic disorderDavid V Sheehan
The Journal of Clinical Psychiatry|October 2, 2001
Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative dataD V Sheehan
The Journal of Clinical Psychiatry|July 1, 1984
Delineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: implications for classificationD V Sheehan
The Journal of Clinical Psychiatry|January 14, 2000
Venlafaxine extended release (XR) in the treatment of generalized anxiety disorderD V Sheehan
Managed Care (Langhorne, Pa.)|August 6, 2004
Depression: underdiagnosed, undertreated, underappreciatedDavid V Sheehan
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1983
The diagnosis and drug treatment of anxiety disordersD V Sheehan
The Psychiatric Clinics of North America|March 1, 1985
Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobiaD V Sheehan
Journal of Affective Disorders|September 1, 1987
Benzodiazepines in panic disorder and agoraphobiaD V Sheehan
The Journal of Clinical Psychiatry|September 16, 1999
Current concepts in the treatment of panic disorderD V Sheehan
Managed Care (Langhorne, Pa.)|September 18, 2002
The importance of adequate length of antidepressant therapyDavid V Sheehan
Pageof 20

Showing results (11-20 of 195) with videos related to

Sort By:
Pageof 20
The Journal of Clinical Psychiatry|February 4, 2003
The management of panic disorderDavid V Sheehan
The Journal of Clinical Psychiatry|October 2, 2001
Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative dataD V Sheehan
The Journal of Clinical Psychiatry|July 1, 1984
Delineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: implications for classificationD V Sheehan
The Journal of Clinical Psychiatry|January 14, 2000
Venlafaxine extended release (XR) in the treatment of generalized anxiety disorderD V Sheehan
Managed Care (Langhorne, Pa.)|August 6, 2004
Depression: underdiagnosed, undertreated, underappreciatedDavid V Sheehan
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1983
The diagnosis and drug treatment of anxiety disordersD V Sheehan
The Psychiatric Clinics of North America|March 1, 1985
Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobiaD V Sheehan
Journal of Affective Disorders|September 1, 1987
Benzodiazepines in panic disorder and agoraphobiaD V Sheehan
The Journal of Clinical Psychiatry|September 16, 1999
Current concepts in the treatment of panic disorderD V Sheehan
Managed Care (Langhorne, Pa.)|September 18, 2002
The importance of adequate length of antidepressant therapyDavid V Sheehan
Pageof 20